Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The JenaValve ALIGN-AR LVAD Registry

NCT: NCT06594705 · ACTIVE_NOT_RECRUITING

NCT IDNCT06594705
StatusACTIVE_NOT_RECRUITING
Start Date2024-12-09
SponsorJenaValve Technology, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

To evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with continuous flow left ventricular assist devices (cfLVAD) and clinically significant aortic regurgitation (AR) who are indicated for TAVR

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑